Qualysec

Blog

Latest Articles

Page 29 of 166 · 1490 posts

Cloud Migration Security Best Practices

April 14, 2026

Cloud Migration Security: Best Practices for 2026

The issue of cloud migration security has taken on a burning priority in the minds of organizations in the USA, as an increasing number of business-critical data, applications, and infrastructure transition to cloud platforms. Although the adoption of cloud enhances scalability and speed, it also opens security vulnerabilities in the process of migration that may […]

Cybersecurity in Premarket Approval (PMA) Applications and PMA Supplements

April 13, 2026

Cybersecurity in Premarket Approval (PMA) Applications and PMA Supplements

You can do everything right on the clinical side and still watch your PMA get blocked before review even begins. That is exactly what is happening to teams that treat cybersecurity as a secondary requirement. At the Premarket Approval level, the FDA does not just evaluate whether your device works. It looks at whether your […]

Top FDA Consultants in Germany -Complete Service Guide

April 10, 2026

Top FDA Consultants in Germany: Complete Service Guide

Germany is also among the world’s most powerful centres for medical device innovation. German companies are increasingly targeting the U.S. market; this trend reflects startups creating software-intensive medical equipment and more established companies seeking to enter new markets across the globe. The FDA is one of the most stringent regulatory organizations in the world and […]

Cybersecurity Requirements for Premarket Notification 510(k) Submissions A Complete Guide for Medical Devices

April 10, 2026

Cybersecurity Requirements for Premarket Notification 510(k) Submissions: A Complete Guide for Medical Devices

Introduction Cybersecurity has moved from a supporting document to a legal requirement in cyber devices related to the healthcare industry for submissions. With the introduction of Section 524B of the FD and C Act in 2023, the FDA now expects cybersecurity documentation to be complete at the time of submission; the file may be refused […]

Secure Medical Device Development Lifecycle Under EU MDR A Practical Guide for Manufacturers

April 10, 2026

Secure Medical Device Development Lifecycle Under EU MDR: A Practical Guide for Manufacturers

Key Takeaways –  EU MDR software development requirements include guidelines that every medical device software needs to follow to achieve CE marking and be sold in Europe. From software design to testing, release, and post-launch monitoring, these standards include cybersecurity in every phase. Certain standards, such as IEC 62304, IEC 62443, and ISO 14971, serve […]

De Novo Requests & Cybersecurity: How to Ensure Faster FDA Approval

April 9, 2026

De Novo Requests & Cybersecurity: How to Ensure Faster FDA Approval

Key Takeaways De Novo means starting from zero. There is no predicate, so your cybersecurity baseline has to be defined and explained clearly Review decisions depend on how well things connect. Risks, controls, and testing should link together, not sit in separate sections Delays usually come from complicated documentation. Even good security work gets questioned […]

A Practical Guide to FDA 510k Cybersecurity Gap Analysis for Medical Devices

April 9, 2026

A Practical Guide to FDA 510k Cybersecurity Gap Analysis for Medical Devices

Following recent FDA QMSR updates aligned with ISO 13485, the FDA has intensified its refusal-to-accept (RTA) criteria for 510(k) submissions.  Software Bill of Materials (SBOM) or a formal Secure Product Development Framework (SPDF) is required for devices classified as ‘cyber devices’ under Section 524B. FDA and CISA advisories show a consistent trend of high-severity vulnerabilities […]

FDA Inspection Readiness: A Complete Guide 2026

April 8, 2026

FDA Inspection Readiness: A Complete Guide 2026

Introduction FDA Inspection readiness means a continuous state of preparation for the USA Food and Drug Administration (FDA) inspection. It is a mandatory requirement for all kinds of organisations that are involved in manufacturing, processing, storage, distribution, or testing of FDA-regulated products, including pharmaceuticals, biologics, medical devices, dietary supplements, food, and cosmetics. Non-compliance can lead […]

BIMO Inspections: A Guide to Basics and Best Practices

April 8, 2026

BIMO Inspections: A Guide to Basics and Best Practices (2026)

A BIMO inspection is an on-site or remote FDA inspection conducted under the Bioresearch Monitoring (BIMO) Program to audit the conduct of research for FDA-regulated products. FDA’s Bioresearch Monitoring (BIMO) is essential for protecting human subjects. It ensures credible clinical data on subjects taken for research. In 2026, BIMO inspections will no longer be limited […]

"Don't compromise between depth and speed. Own both. Connect with Swagat, Your trusted penetration testing advisor."

Swagat Kumar Dash

Swagat Kumar Dash

Head Of Business Development